NYtor is a knowledge-driven and reliable developer of innovative molecular diagnostic assays. Our company employs an enthusiastic and motivated team of highly skilled professionals with more than 30 years of expert experience and state-of-the-art knowledge of molecular diagnostic assay development.
Tailor-made applications and approaches are important aspects of our services, with a focus on long-term relationships based on personal interactions.
In close harmony with our customer, NYtor develops prototype molecular assays and works together with a broad network of carefully selected suppliers and partners. This results in a high-quality test development in which both the demands of our clients as well as the ISO 13485:2016 regulations are considered.Read more
NYtor designs and develops smart molecular detection assays for a broad range of applications, in collaboration with different partners. Our strength lies in the development of qPCR and point-of-care assays with main focus on early cancer screening and the detection of pathogens and antibiotic resistance.